writing group collaborators-online appendix global burden ... · niveen m e abu-rmeileh, phd,...
TRANSCRIPT
Writing group collaborators-online appendix
Global Burden of Disease Collaborators on Eastern Mediterranean Region and Diabetes:
Maziar Moradi-Lakeh, MD, Institute for Health Metrics and Evaluation, University of
Washington, Seattle, WA, US; Department of Community Medicine, Preventive Medicine and
Public Health Research Center, Iran University of Medical Sciences, Tehran, Iran
Mohammad H Forouzanfar, PhD, Institute for Health Metrics and Evaluation, University of
Washington, Seattle, WA, US
Charbel El Bcheraoui, PhD, Institute for Health Metrics and Evaluation, University of
Washington, Seattle, WA, US
Farah Daoud, BS, Institute for Health Metrics and Evaluation, University of Washington, Seattle,
WA, US
Raghid Charara, MD, Institute for Health Metrics and Evaluation, University of Washington,
Seattle, WA, US
Ashkan Afshin, ScD, Institute for Health Metrics and Evaluation, University of Washington,
Seattle, WA, US
Ibrahim Abdel-Messih Khalil, MD, MPH, Institute for Health Metrics and Evaluation,
University of Washington, Seattle, WA, US
Marie Ng, PhD, Institute for Health Metrics and Evaluation, University of Washington, Seattle,
WA, US
Danny Colombara, PhD, Institute for Health Metrics and Evaluation, University of Washington,
Seattle, WA, US
Sarah Wulf Hanson, MPH, Institute for Health Metrics and Evaluation, University of
Washington, Seattle, WA, US
Kalkidan Hassen Abate, MS, Jimma University, Jimma, Ethiopia
Mohamed Magdy Abd El Razek, MBBCh, Ophthalmology resident in Aswan University
Hospital, Aswan, Egypt
SUPPLEMENTARY DATA
©2018 American Diabetes Association. Published online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc16-1075/-/DC1
Foad Abd-Allah, MD, Department of Neurology, Cairo University, Cairo, Egypt
Mahmud A Abdallat, MPH, Royal Jordanian Medical Services, Amman, Jordan
Laith J Abu-Raddad, PhD, Infectious Disease Epidemiology Group, Weill Cornell Medical
College in Qatar, Doha, Qatar
Niveen M E Abu-Rmeileh, PhD, Institute of Community and Public Health, Birzeit University,
Ramallah, Palestine
Aliasghar Ahmad Kiadaliri, PhD, Clinical Epidemiology Unit, Orthopaedics, Department of
Clinical Sciences-Lund, Lund University, Lund, Sweden; Kerman University of Medical
Sciences, Kerman, Iran
Nadia Akseer, PhD Candidate, Centre for Global Child Health, Hospital for Sick Children,
Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto,
Ontario, Canada
Zulfa A Al Rayess, MD, The Saudi Center for Evidence Based Healthcare, Kingdom of Saudi
Arabia Ministry of Health, Riyadh, Saudi Arabia
Ziyad Al-Aly, MD, Washington University in Saint Louis, Saint Louis, MO, US
Khurshid Alam, PhD, Murdoch Childrens Research Institute, Melbourne, VIC, Australia; The
University of Melbourne, Melbourne, VIC, Australia; The University of Sydney, Sydney, NSW,
Australia
Deena Alasfoor, MSc, Ministry of Health, Al Khuwair, Oman
Raghib Ali, FRCP, University of Oxford, Oxford, UK
Ala’a Alkerwi, PhD, Luxembourg Institute of Health, Strassen, Luxembourg
Mohammad AbdulAziz AlMazroa, MD, Saudi Ministry of Health, Riyadh, Saudi Arabia
Abdulwahab A Al-Nehmi, MD, Ministry of Health, Sana’a, Yemen
Mahmoud A Alomari, PhD, Division of Physical Therapy, Department of Rehabilitation
Sciences, Faculty of Applied Medical Sciences, Jordan University of Science and Technology,
Irbid, Jordan
SUPPLEMENTARY DATA
©2018 American Diabetes Association. Published online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc16-1075/-/DC1
Rajaa Mohammad Salem Al-Raddadi, PhD, Ministry of Health, Jeddah, Saudi Arabia
Shirina Alsowaidi, MD, United Arab Emirates University, Al Ain, UAE
Khalid A Altirkawi, MD, King Saud University, Riyadh, Saudi Arabia
Walid Ammar, PhD, Ministry of Public Health, Beirut, Lebanon
Stephen Marc Amrock, MD, Oregon Health & Science University, Portland, OR, US
Hamid Asayesh, PhD, Department of Medical Emergency, School of Paramedic, Qom
University of Medical Sciences, Qom, Iran
Rana Jawad Asghar, MD, South Asian Public Health Forum, Islamabad, Pakistan
Reza Assadi, PhD, Mashhad University of Medical Sciences, Mashhad, Iran
Suleman Atique, MS, Graduate Institute of Biomedical Informatics, Taipei Medical University,
Taipei, Taiwan
Umar Bacha, PhD, School of Health Sciences, University of Management and Technology,
Lahore, Pakistan
Alaa Badawi, PhD, Public Health Agency of Canada, Toronto, ON, Canada
Aleksandra Barac, PhD, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
Shahrzad Bazargan-Hejazi, PhD, Charles R. Drew University of Medicine and Science, Los
Angeles, CA, US
Neeraj Bedi, MD, College of Public Health and Tropical Medicine, Jazan, Saudi Arabia
Adugnaw Berhane, PhD, College of Health Sciences, Debre Berhane University, Debre Berhan,
Ethiopia
Balem Demtsu Betsu, MS, Mekelle Uniersity, Mekelle, Ethiopia
Sibhatu Biadgilign, MPH, Independent Public Health Consultants, Addis Ababa, Ethiopia
Ismael Ricardo Campos-Nonato, PhD, National Institute of Public Health, Cuernavaca, Mexico;
T.H. Chan School of Public Health, Harvard University, Boston, MA, US
SUPPLEMENTARY DATA
©2018 American Diabetes Association. Published online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc16-1075/-/DC1
David O Carpenter, MD, University at Albany, Rensselaer, NY, US
Ferran Catala-Lopez, PhD, Department of Medicine, INCLIVA Health Research Institute and
CIBERSAM, University of Valencia, Valencia, Spain; Clinical Epidemiology Program, Ottawa
Hospital Research Institute, Ottawa, Canada
Rajiv Chowdhury, PhD, Department of Public Health and Primary Care, University of
Cambridge, Cambridge, UK
Hadi Danawi, PhD, Walden University, Minneapolis, MN, US
Amare Deribew, MD, PhD, Nuffield Department of Medicine, Oxford University, Oxford, UK;
KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya; St. Paul Millennium Medical
College, Addis Ababa, Ethiopia
Samath D Dharmaratne, MD, Department of Community Medicine, Faculty of Medicine,
University of Peradeniya, Peradeniya, Sri Lanka
Eric L Ding, ScD, T.H. Chan School of Public Health, Harvard University, Boston, MA, US
Bruce B Duncan, PhD, Federal University of Rio Grande do Sul, Porto Alegre, Brazil;
University of North Carolina, Chapel Hill, NC, US
Babak Eshrati, PhD, Ministry of Health and Medical Education, Tehran, Iran; Arak University of
Medical Sciences, Arak, Iran
Alireza Esteghamati, MD, Endocrinology and Metabolism Research Center, Tehran University
of Medical Sciences, Tehran, Iran
Talha A Farid, MD, University of Louisville, Louisville, KY, US
Maryam S Farvid, PhD, Department of Nutrition, Harvard T.H. Chan School of Public Health,
Harvard University, Boston, MA, US; Harvard/MGH Center on Genomics, Vulnerable
Populations, and Health Disparities, Mongan Institute for Health Policy, Massachusetts General
Hospital, Boston, MA, US
Seyed-Mohammad Fereshtehnejad, MD, Department of Neurobiology, Care Sciences and
Society (NVS), Karolinska Institute, Stockholm, Sweden
SUPPLEMENTARY DATA
©2018 American Diabetes Association. Published online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc16-1075/-/DC1
João C Fernandes, PhD, Centre for Experimental Medicine & Rheumatology, William Harvey
Research Institute, Barts and The London School of Medicine & Dentistry, Queen Mary
University of London, London, UK
Florian Fischer, MPH, Bielefeld University, Bielefeld, Germany
Alemseged Aregay Gebru, MPH, Mekelle University, Mekelle, Ethiopia; Kilte Awlaelo-Health
and Demographic Surveillance System, Mekelle University, Mekelle, Ethiopia
Melkamu Dedefo Gishu, MS, Haramaya University, Dire Dawa, Ethiopia; Kersa Health and
Demographic Surveillance System, Harar, Ethiopia
Philimon Gona, PhD, University of Massachusetts Boston, Boston, MA, US
Sameer Vali Gopalani, MPH, Department of Health and Social Affairs, Government of the
Federated States of Micronesia, Palikir, Federated States of Micronesia
Atsushi Goto, MD, Division of Epidemiology, Center for Public Health Sciences, National
Cancer Center, Tokyo, Japan
Rahul Gupta, MD, West Virginia Bureau for Public Health, Charleston, WV, US
Vipin Gupta, PhD, University of Delhi, Delhi, India
Nima Hafezi-Nejad, MD, Endocrinology and Metabolism Research Center, Tehran University of
Medical Sciences, Tehran, Iran
Randah Ribhi Hamadeh, DPhil, Arabian Gulf University, Manama, Bahrain
Samer Hamidi, PhD, Hamdan Bin Mohammed Smart University, Dubai, United Arab Emirates
Graeme J Hankey, MD, School of Medicine and Pharmacology, The University of Western
Australia, Perth, WA, Australia; Harry Perkins Institute of Medical Research, Nedlands, WA,
Australia; Western Australian Neuroscience Research Institute, Nedlands, WA, Australia
Hilda L Harb, MPH, Ministry of Public Health, Beirut, Lebanon
Ileana Beatriz Heredia-Pi, PhD, National Institute of Public Health, Cuernavaca, Mexico
SUPPLEMENTARY DATA
©2018 American Diabetes Association. Published online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc16-1075/-/DC1
Masako Horino, MPH, Nevada Division of Behavior and Public Health, Carson City, NV, US;
Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA, US
Mohamed Hsairi, MD, National Institute of Public Health, Tunis, Tunisia
Abdullatif Husseini, PhD, Institute of Community and Public Health, Birzeit University, Birzeit,
Palestine
Inge Huybrechts, PhD, International Agency for Research on Cancer, Lyon, France; Ghent
University, Ghent, Belgium
Mihajlo B Jakovljevic, PhD, Faculty of Medical Sciences, University of Kragujevac,
Kragujevac, Serbia
Jost B Jonas, MD, Department of Ophthalmology, Medical Faculty Mannheim, Ruprecht-Karls-
University Heidelberg, Mannheim, Germany
Edmond Kato Kabagambe, PhD, Vanderbilt University, Nashville, TN, US
Amir Kasaeian, PhD, Non-Communicable Diseases Research Center, Endocrinology and
Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran;
Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran University of
Medical Sciences, Tehran, Iran
Yousef Saleh Khader, ScD, Jordan University of Science and Technology, Irbid, Jordan
Abdul Sattar Khan, MD, Family & Community Medicine Department, College of Medicine,
King Faisal University, Alhafof, Saudi Arabia
Abdur Rahman Khan, MD, University of Louisville, Louisville, KY, US
Ejaz Ahmad Khan, MPH, Health Services Academy, Islamabad, Pakistan; Expanded Programme
on Immunization, Islamabad, Pakistan
Tawfik Ahmed Muthafer Khoja, FRCP, Executive Board of the Health Ministers’ Council for
Cooperation Council States, Riyadh, Saudi Arabia
Daniel Kim, DrPH, Department of Health Sciences, Northeastern University, Boston, MA, US
Yun Jin Kim, PhD, Southern University College, Skudai, Malaysia
SUPPLEMENTARY DATA
©2018 American Diabetes Association. Published online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc16-1075/-/DC1
Yohannes Kinfu, PhD, University of Canberra, Canberra, ACT, Australia
Yoshihiro Kokubo, PhD, Department of Preventive Cardiology, National Cerebral and
Cardiovascular Center, Suita, Japan
Dhaval Kolte, MD, Brown University/Rhode Island Hospital, Providence, RI, US
Georgios A Kotsakis, DDS, School of Dentistry, University of Washington, Seattle, WA, US
Ai Koyanagi, MD, Research and Development Unit, Parc Sanitari Sant Joan de Deu
(CIBERSAM), Barcelona, Spain
Asma Abdul Latif, PhD, Department of Zoology, Lahore College for Women University,
Lahore, Pakistan
Raimundas Lunevicius, PhD, Aintree University Hospital National Health Service Foundation
Trust, Liverpool, UK; School of Medicine, University of Liverpool, Liverpool, UK
Azeem Majeed, MD, Imperial College London, London, UK
Reza Malekzadeh, MD, Digestive Disease Research Institute, Tehran Universities of Medical
Sciences, Tehran, Iran
Peter A Meaney, MD, Pereleman School of Medicine, University of Pennsylvania, Philadelphia,
PA, US; Children’s Hospital of Philadelphia, Philadelphia, PA, US
Alem Mehari, MD, College of Medicine, Howard University, Washington, DC, US
Alemayehu B Mekonnen, MS, University of Gondar, Gondar, Ethiopia; The University of
Sydney, Sydney, NSW, Australia
Yohannes Adama Melaku, MPH, School of Public Health, Mekelle University, Mekelle,
Ethiopia; School of Medicine, The University of Adelaide, Adelaide, SA, Australia
Ziad A Memish, MD, Saudi Ministry of Health, Riyadh, Saudi Arabia; College of Medicine,
Alfaisal University, Riyadh, Saudi Arabia
Walter Mendoza, MD, United Nations Population Fund, Lima, Peru
SUPPLEMENTARY DATA
©2018 American Diabetes Association. Published online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc16-1075/-/DC1
Ted R Miller, PhD, Pacific Institute for Research & Evaluation, Calverton, MD, US; Curtin
University Centre for Population Health, Perth, WA, Australia
Mojde Mirarefin, MPH, Institute for Health Metrics and Evaluation, University of Washington,
Seattle, WA, US
Layla Abdalla Ibrahim Mohamed, MPH, Federal Ministry of Health, Khartoum, Sudan
Alireza Mohammadi, PhD, Neuroscience Research Center, Baqiyatallah University of Medical
Science, Tehran, Iran
Shafiu Mohammed, PhD, Health Systems and Policy Research Unit, Ahmadu Bello University,
Zaria, Nigeria; Institute of Public Health, Heidelberg University, Heidelberg, Germany
Dariush Mozaffarian, MD, DrPH, Friedman School of Nutrition Science and Policy, Tufts
University, Boston, MA, US
Ulrich O Mueller, PhD, Competence Center Mortality-Follow-Up of the German National
Cohort, Federal Institute for Population Research, Wiesbaden, Germany
Chakib Nejjari, PhD, Université Sidi Mohamed Ben Abdellah, Fès, Morocco
Muhammad Imran Nisar, MSc, Aga Khan University, Karachi, Pakistan
Erika Ota, PhD, St. Luke’s International University, Tokyo, Japan
Max Petzold, PhD, Health Metrics Unit, University of Gothenburg, Gothenburg, Sweden;
University of the Witwatersrand, Johannesburg, South Africa
Farshad Pourmalek, PhD, University of British Columbia, Vancouver, BC, Canada
Mostafa Qorbani, PhD, Department of Community Medicine, School of Medicine, Alborz
University of Medical Sciences, Karaj, Iran
Anwar Rafay, MS, Contech School of Public Health, Lahore, Pakistan
Kazem Rahimi, DM, University of Oxford, Oxford, UK
Mahfuzar Rahman, PhD, Research and Evaluation Division, BRAC, Dhaka, Bangladesh
SUPPLEMENTARY DATA
©2018 American Diabetes Association. Published online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc16-1075/-/DC1
Mohammad Hifz Ur Rahman, MPhil, International Institute for Population Sciences, Mumbai,
India
Sajjad Ur Rahman, FCPS, FRCPHC, Neonatal Intensive Care Unit, Sweidi Hospital, Riyadh,
Saudi Arabia
Rajesh Kumar Rai, MPH, Society for Health and Demographic Surveillance, Suri, India
Saleem M Rana, PhD, Contech School of Public Health, Lahore, Pakistan; Contech International
Health Consultants, Lahore, Pakistan
Amany H Refaat, PhD, Walden University, Minneapolis, MN, US, Suez Canal University,
Ismailia, Egypt
Serge Resnikoff, MD, Brien Holden Vision Institute, Sydney, NSW, Australia; School of
Optometry and Vision Science, University of New South Wales, Sydney, NSW, Australia
Gholamreza Roshandel, PhD, Golestan Research Center of Gastroenterology and Hepatology,
Golestan University of Medical Sciences, Gorgan, Iran; Digestive Diseases Research Institute,
Tehran University of Medical Sciences, Tehran, Iran
Shadi Saleh, PhD, Department of Health Management and Policy, American University of
Beirut, Beirut, Lebanon
Juan R Sanabria, MD, MSc, Case Western Reserve University, Cleveland, OH, US; Marshall
University School of Medicine, Huntington, WV, US
Itamar S Santos, PhD, Internal Medicine Department, University of São Paulo, São Paulo, Brazil
Benn Sartorius, PhD, University of KwaZulu-Natal, Durban, South Africa
Monika Sawhney, PhD, Marshall University, Huntington, WV, US
Maria Inês Schmidt, MD, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
Ben Schöttker, MPH, Division of Clinical Epidemiology and Aging Research, German Cancer
Research Center, Heidelberg, Germany; Institute of Health Care and Social Sciences, FOM
University, Essen, Germany
SUPPLEMENTARY DATA
©2018 American Diabetes Association. Published online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc16-1075/-/DC1
Sadaf G Sepanlou, PhD, Digestive Diseases Research Institute, Tehran University of Medical
Sciences, Tehran, Iran
Sara Sheikhbahaei, MD, Endocrinology and Metabolism Research Centre, Tehran University of
Medical Sciences, Tehran, Iran
Kawkab Shishani, PhD, Washington State University, Spokane, WA, US
Abla Mehio Sibai, PhD, Department of Epidemiology & Population Health, Faculty of Health
Sciences, American University of Beirut, Beirut, Lebanon
Dayane Gabriele Alves Silveira, MD, Department of Health Science, Brasília University,
Brasília, Brazil
Karen Sliwa, PhD, Faculty of Health Sciences, Hatter Institute for Cardiovascular Research in
Africa, University of Cape Town, Cape Town, South Africa
Rafael Tabarés-Seisdedos, PhD, Department of Medicine, University of Valencia INCLIVA
Health Research Institute and CIBERSAM, Valencia, Spain
Karen M Tabb, PhD, School of Social Work, University of Illinois at Urbana-Champaign,
Champaign, IL, US
Mohammad Tavakkoli, MD, Westchester Medical Center, New York Medical College, Valhalla,
NY, US
Marcello Tonelli, MD, University of Calgary, Calgary, AB, Canada
Roman Topor-Madry, PhD, Institute of Public Health, Jagiellonian University, Krakow, Poland;
Casimir the Great Foundation of Innovation and Development, Krakow, Poland
Jaako Tuomilehto, MD, University of Helsinki Department of Public Health, Finland
Stefanos Tyrovolas, PhD, Parc Sanitari Sant Joan de Déu, Fundacio Sant Joan de Déu,
Universitat de Barcelona, San Boi, Barcelona, Spain
Kingsley N Ukwaja, MD, Department of Internal Medicine, Federal Teaching Hospital,
Abakaliki, Nigeria
Olalekan A Uthman, PhD, Warwick Medical School, University of Warwick, Coventry, UK
SUPPLEMENTARY DATA
©2018 American Diabetes Association. Published online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc16-1075/-/DC1
Andrea Werdecker, PhD, Competence Center Mortality-Follow-Up of the German National
Cohort, Federal Institute for Population Research, Wiesbaden, Germany
Yuichiro Yano, MD, Department of Preventive Medicine, Northwestern University, Chicago, IL,
US
Naohiro Yonemoto, MPH, Department of Biostatistics, School of Public Health, Kyoto
University, Kyoto, Japan
Mustafa Z Younis, DrPH, Jackson State University, Jackson, MS, US
Zoubida Zaidi, PhD, University Hospital, Setif, Algeria
Maysaa El Sayed Zaki, PhD, Mansoura Faculty of Medicine, Mansoura, Egypt
Zulfiqar A Bhutta, PhD, Center of Excellence in Women and Child Health, The Aga Khan
University, Karachi, Pakistan
Abdullah A. Al-Rabeeah, MBBS, Saudi Ministry of Health, Riyadh, Saudi Arabia
Haidong Wang, PhD, Institute for Health Metrics and Evaluation, University of Washington,
Seattle, WA, US
Theo Vos, PhD, Institute for Health Metrics and Evaluation, University of Washington, Seattle,
WA, US
Mohsen Naghavi, PhD, Institute for Health Metrics and Evaluation, University of Washington,
Seattle, WA, US
Alan D Lopez, PhD, Melbourne School of Population and Global Health, University of
Melbourne, Melbourne, VIC, Australia; Institute for Health Metrics and Evaluation, University
of Washington, Seattle, WA, US
Christopher J L Murray, DPhil, Institute for Health Metrics and Evaluation, University of
Washington, Seattle, WA, US
Ali H Mokdad, PhD, Institute for Health Metrics and Evaluation, University of Washington,
Seattle, WA, US
SUPPLEMENTARY DATA
©2018 American Diabetes Association. Published online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc16-1075/-/DC1
1
Supplementa Table 1. Age-sex-specific death rates of diabetes mellitus (per 100,000 population) in the Eastern Mediterranean region,
1990 and 2013
ry
Age group
Male Female Both sexes
1990 2013 1990 2013 1990 2013
Rate 95% UI Rate 95% UI Rate 95% UI Rate 95% UI Rate 95% UI Rate 95% UI
Under 5 2.0 1.6 2.5 1.5 1.2 1.9 1.6 0.9 2.5 0.9 0.5 1.4 1.8 1.4 2.3 1.2 0.9 1.5
5 to 9 0.4 0.3 0.5 0.3 0.2 0.4 0.4 0.2 0.6 0.2 0.1 0.4 0.4 0.3 0.5 0.3 0.2 0.4
10 to 14 0.4 0.3 0.6 0.4 0.3 0.5 0.7 0.4 1.1 0.5 0.3 0.9 0.5 0.4 0.8 0.4 0.3 0.6
15 to 19 0.6 0.5 0.8 0.5 0.4 0.7 0.9 0.5 1.6 0.8 0.4 1.3 0.8 0.6 1.1 0.6 0.5 0.9
20 to 24 1.5 1.1 1.9 1.7 1.1 2.6 1.6 0.9 2.5 1.4 0.7 2.3 1.5 1.1 2.0 1.6 1.1 2.2
25 to 29 1.5 1.3 1.8 1.4 1.1 1.8 1.8 1.4 2.2 1.9 1.3 2.6 1.7 1.4 1.9 1.6 1.3 2.1
30 to 34 2.6 2.1 3.2 2.8 2.0 4.0 2.5 1.9 3.0 2.7 1.9 3.6 2.5 2.2 2.9 2.8 2.2 3.5
35 to 39 4.0 3.3 4.9 4.6 3.3 6.5 3.8 3.0 4.7 4.2 3.0 5.6 3.9 3.4 4.5 4.4 3.5 5.6
40 to 44 6.9 5.7 8.6 8.2 6.0 11.0 6.6 5.4 8.0 7.3 5.5 9.5 6.8 5.9 7.9 7.8 6.3 9.6
45 to 49 13.3 10.9 16.3 16.4 12.6 22.0 13.5 11.1 16.4 14.6 11.2 19.2 13.4 11.6 15.6 15.6 12.8 19.0
50 to 54 23.7 19.8 28.4 30.4 24.0 38.0 26.0 21.5 31.5 29.0 22.5 37.0 24.8 21.7 28.3 29.7 24.7 35.5
55 to 59 41.3 34.0 50.4 54.5 43.3 69.6 43.5 35.7 52.0 51.6 41.3 64.0 42.3 36.7 49.1 53.0 45.1 63.3
60 to 64 69.4 57.6 82.5 93.0 75.0 116.4 81.8 67.7 98.8 93.3 74.1 117.0 75.5 65.4 87.3 93.1 79.8 108.9
65 to 69 107.0 88.8 131.9 148.7 118.6 185.3 126.6 106.0 151.6 152.1 121.9 191.7 116.8 102.7 134.8 150.5 127.5 176.7
70 to 74 167.3 136.9 202.5 236.8 186.0 302.2 184.5 153.9 225.7 238.3 191.2 301.1 176.0 153.6 203.1 237.5 199.6 280.7
75 to 79 248.5 203.8 302.0 352.9 285.8 430.2 261.2 219.8 314.7 359.9 292.1 438.0 255.0 223.8 295.7 356.6 308.4 408.0
80 plus 415.0 339.3 518.2 613.6 501.1 741.1 423.3 351.8 512.5 695.5 551.4 841.9 419.5 366.5 490.6 658.4 572.6 754.9
All ages 11.3 10.1 12.6 18.1 15.5 20.8 13.0 11.7 14.7 20.9 18.1 24.1 12.1 11.2 13.2 19.5 17.4 21.5
Age-
standardized 30.0 26.9 33.9 41.8 35.7 48.0 32.3 28.8 36.6 43.5 37.4 50.2 31.2 28.9 34.0 42.7 38.3 47.1
SUPPLEMENTARY DATA
©2018 American Diabetes Association. Published online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc16-1075/-/DC1
2
Supplementa Table 2. Age-specific disability-adjusted life year (DALY) rates of diabetes mellitus in the Eastern Mediterranean region
compared to global estimates, 1990 and 2013
ry
Age group
1990 2013
Global EMR Global EMR
Rate 95% UI Rate 95% UI Rate 95% UI Rate 95% UI
Under 5 115.7 95.9 143.8 164.6 131.2 207.6 67.4 55.5 82.7 115.0 90.9 143.7
5 to 9 39.5 30.1 50.6 59.9 45.9 77.2 39.1 28.3 53.8 59.0 42.3 79.9
10 to 14 60.8 45.6 79.6 88.4 66.7 115.5 66.1 47.3 90.3 94.2 67.0 127.7
15 to 19 93.6 70.3 122.5 124.5 93.9 163.1 107.1 77.7 144.5 138.4 97.8 186.4
20 to 24 155.3 121.6 197.0 209.8 161.9 267.2 185.9 141.6 240.6 245.9 183.0 320.5
25 to 29 213.6 168.1 270.4 284.8 218.8 361.0 265.4 202.2 343.6 336.0 248.7 440.9
30 to 34 309.2 243.9 387.7 417.9 324.2 532.1 380.1 294.6 483.2 514.8 382.5 668.0
35 to 39 434.1 344.5 542.5 612.4 473.7 776.1 538.7 414.3 682.5 767.1 573.3 992.6
40 to 44 628.5 505.4 788.0 948.1 744.8 1,194.5 783.8 611.2 991.1 1,190.2 910.5 1,531.3
45 to 49 966.8 783.0 1,171.9 1,529.5 1,215.6 1,891.7 1,184.5 928.5 1,476.1 1,918.6 1,484.1 2,434.4
50 to 54 1,326.3 1,101.2 1,600.2 2,112.7 1,689.1 2,591.2 1,622.3 1,305.7 1,980.4 2,713.5 2,140.9 3,358.9
55 to 59 1,708.6 1,458.5 1,996.6 2,625.7 2,154.3 3,161.1 2,054.2 1,693.7 2,469.7 3,423.7 2,782.5 4,129.8
60 to 64 2,144.3 1,857.2 2,457.7 3,302.7 2,785.9 3,857.5 2,455.3 2,061.7 2,885.1 4,211.7 3,499.1 4,964.9
65 to 69 2,545.2 2,227.1 2,877.7 3,847.7 3,300.6 4,476.9 3,013.7 2,582.9 3,470.3 4,950.4 4,215.7 5,756.4
70 to 74 2,842.1 2,523.0 3,202.5 4,374.0 3,781.9 5,072.4 3,308.8 2,860.1 3,802.1 5,788.4 4,923.5 6,782.7
75 to 79 2,883.3 2,558.9 3,234.2 4,663.6 4,088.0 5,366.2 3,536.9 3,105.5 4,040.5 6,314.5 5,493.7 7,228.3
80 plus 2,319.6 2,060.9 2,631.3 4,022.2 3,522.1 4,651.8 3,012.5 2,640.7 3,438.0 5,823.4 5,098.3 6,601.3
All ages 532.0 453.4 622.8 589.9 498.0 698.0 779.2 647.2 932.4 883.5 732.2 1,051.5
Age-standardized 706.3 602.1 821.2 1,086.7 927.9 1,273.3 844.8 703.7 1,005.8 1,397.6 1,179.6 1,639.3
SUPPLEMENTARY DATA
©2018 American Diabetes Association. Published online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc16-1075/-/DC1
3
Supplementa Table 3. All-age and age-standardized death and disability-adjusted life year (DALY) rates of diabetes mellitus in the
Eastern Mediterranean countries, 2013
ry
Location Sex
All ages Age-standardized
DALYs per 1,000 Deaths per 100,000 YLL/DALY
DALYs per 1,000 Deaths per 100,000
Rate 95% UI Rate 95% UI Rate 95% UI Rate 95% UI
Afghanistan Male 7.9 5.6 10.5 19.4 12.7 27.1 71% 19.5 13.8 25.9 69.7 47.2 93.4
Female 10.4 7.3 14.6 31.6 21.2 46.0 84% 24.1 17.1 33.7 97.2 67.3 138.8
Bahrain Male 14.1 10.6 18.2 19.4 15.0 25.0 34% 23.3 18.3 29.2 76.6 60.7 98.7
Female 14.7 10.9 19.3 24.4 18.7 31.3 34% 24.3 18.7 30.5 75.1 58.5 94.5
Djibouti Male 5.9 4.4 8.6 18.9 13.7 28.4 78% 11.0 8.2 15.9 47.9 36.1 69.4
Female 5.4 3.7 7.7 19.1 11.9 29.0 76% 9.8 6.7 13.9 43.9 27.6 64.9
Egypt Male 9.9 7.9 12.5 22.5 19.4 26.1 53% 14.1 11.4 17.4 42.0 36.2 48.7
Female 11.6 9.3 14.6 27.8 23.1 32.8 48% 15.0 12.1 18.7 41.7 34.5 49.2
Iran Male 5.1 3.7 6.7 8.6 6.9 10.4 35% 6.7 4.9 8.8 14.7 12.0 17.8
Female 7.2 5.1 9.8 9.4 7.2 11.7 25% 9.1 6.6 12.3 16.5 12.7 20.3
Iraq Male 8.7 6.6 11.4 16.2 11.6 22.5 50% 17.5 13.1 23.0 48.3 34.8 66.9
Female 10.9 8.2 13.9 25.8 17.9 33.5 56% 20.1 15.2 25.3 62.6 44.1 80.2
Jordan Male 11.0 8.3 14.5 15.1 12.1 19.1 30% 19.1 14.5 24.4 44.0 35.3 54.8
Female 11.3 8.3 15.2 16.2 12.5 19.6 27% 19.8 14.8 26.1 48.1 37.2 58.6
Kuwait Male 12.3 8.5 16.3 6.4 5.5 7.3 10% 17.9 13.1 23.6 24.9 21.2 29.2
Female 8.5 6.0 11.6 6.9 5.9 8.2 17% 15.0 11.0 19.7 31.2 26.1 36.9
Lebanon Male 13.2 9.7 17.5 22.0 15.9 29.8 30% 13.5 9.9 17.8 27.0 19.7 36.3
Female 10.5 7.6 13.8 18.9 13.9 25.3 30% 11.4 8.3 15.1 21.9 16.1 29.2
Libya Male 11.5 8.0 15.5 16.7 11.2 22.8 31% 16.5 11.8 22.0 34.7 23.1 47.7
Female 13.8 10.2 18.4 21.2 15.2 28.3 29% 19.4 14.4 25.2 40.1 28.5 54.0
Morocco Male 12.8 10.3 16.3 38.9 31.4 49.0 58% 19.5 16.1 23.9 87.7 71.4 109.0
Female 15.3 11.8 19.5 63.9 50.2 82.3 65% 21.3 16.7 26.8 112.3 88.6 144.3
Oman Male 9.8 7.5 12.7 22.3 16.1 27.5 48% 24.8 19.5 30.8 87.8 64.4 106.2
Female 10.9 8.1 14.0 25.8 18.5 33.4 47% 21.7 16.4 27.8 68.4 49.4 87.5
SUPPLEMENTARY DATA
©2018 American Diabetes Association. Published online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc16-1075/-/DC1
4
Pakistan Male 9.4 6.9 12.1 24.3 15.1 31.6 59% 15.1 10.8 19.1 53.1 33.2 69.5
Female 7.9 5.8 10.4 19.6 12.6 28.1 57% 12.5 9.0 16.4 42.6 27.3 61.6
Palestine Male 7.7 5.9 10.2 10.3 7.6 13.9 42% 14.7 11.0 19.8 30.6 22.5 41.3
Female 8.9 6.2 12.1 9.5 7.1 13.0 27% 16.6 11.6 22.4 28.3 21.2 39.2
Qatar Male 10.0 6.6 14.2 6.3 5.1 7.6 15% 19.3 14.9 25.0 68.2 56.0 80.6
Female 10.3 7.3 13.9 12.6 9.8 15.4 21% 22.2 16.9 28.2 82.7 65.8 99.6
Saudi
Arabia
Male 14.7 10.3 20.6 7.3 5.8 9.2 10% 20.6 14.9 27.9 23.5 18.8 29.8
Female 14.3 10.1 19.3 7.7 6.4 9.5 8% 22.1 15.7 29.2 18.7 15.6 22.9
Somalia Male 4.2 3.0 6.2 12.8 8.6 19.7 80% 10.1 7.1 14.8 42.4 29.0 63.7
Female 3.1 2.1 4.3 9.8 5.9 14.6 72% 7.2 4.9 9.9 26.7 18.0 43.0
Sudan Male 5.1 3.8 6.7 10.9 7.8 15.6 52% 10.3 7.8 13.7 32.9 23.8 46.8
Female 5.9 4.2 7.8 14.1 9.6 21.1 54% 11.4 8.2 15.7 38.6 26.4 58.5
Syria Male 6.7 4.5 9.3 4.9 3.6 6.0 16% 10.7 7.3 14.8 11.7 8.5 14.5
Female 7.6 5.1 10.7 5.0 3.4 6.6 13% 11.8 8.0 16.3 11.3 7.8 15.0
Tunisia Male 8.8 6.2 12.2 18.2 12.1 27.4 38% 10.1 7.1 13.7 26.3 17.4 39.5
Female 9.6 6.9 13.1 21.0 14.6 32.6 35% 10.2 7.4 14.0 26.6 18.5 41.2
UAE Male 6.7 4.5 9.4 3.7 2.5 5.2 19% 15.9 11.6 20.3 40.6 28.8 54.0
Female 7.0 4.8 9.9 4.1 2.4 6.8 18% 17.8 13.0 24.5 43.3 26.2 71.6
Yemen Male 3.0 2.0 4.4 9.2 5.4 14.7 76% 7.3 4.7 10.7 31.2 19.2 47.7
Female 6.3 4.1 9.2 18.5 10.1 28.2 70% 14.0 9.0 20.2 55.4 31.8 81.6
EMR Male 8.6 7.0 10.4 18.1 15.5 20.8 48% 13.8 11.6 16.3 41.8 35.7 48.0
Female 9.1 7.4 11.0 20.9 18.1 24.1 48% 14.1 11.7 16.8 43.5 37.4 50.2
SUPPLEMENTARY DATA
©2018 American Diabetes Association. Published online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc16-1075/-/DC1
5
Supplementa Table 4. Attributable diabetes burden to each risk factor of diabetes and ranking of risk factors in the Eastern
Mediterranean region (EMR) and countries of the region compared to the global level, 2013
ry
Location High body-mass index Diet low in whole grains Low physical activity
Diet high in processed meat
Rank Rate 95% UI Rank Rate 95% UI Rank Rate 95% UI Rank Rate 95% UI
Global 1 387 307 480 2 163 115 214 3 114 76 161 4 68 45 100
EMR 1 579 461 706 2 185 130 245 3 146 98 202 8 20 7 42
Bahrain 1 1,139 864 1,472 2 371 244 521 3 258 167 370 8 31 6 79
Egypt 1 798 632 990 2 259 178 348 3 188 125 263 9 8 1 27
Iran 1 411 296 542 2 148 97 212 3 101 64 150 7 7 1 21
Iraq 1 694 540 872 2 221 149 308 3 160 105 226 8 6 1 22
Jordan 1 818 607 1,082 2 279 183 395 3 199 127 291 8 9 1 32
Kuwait 1 914 641 1,229 2 303 189 431 3 203 126 299 8 34 9 83
Lebanon 1 844 629 1,103 2 277 183 395 3 217 139 319 8 14 3 41
Libya 1 950 693 1,242 2 297 189 424 3 227 146 330 8 17 3 49
Morocco 1 919 729 1,159 2 294 204 402 3 254 174 356 9 8 1 29
Palestine 1 538 393 711 2 177 113 252 3 125 80 181 8 4 0 16
Oman 1 668 506 858 2 242 163 340 3 184 120 265 8 20 5 52
Qatar 1 843 582 1,175 2 281 167 421 3 173 105 266 8 47 13 109
Saudi Arabia 1 1,145 804 1,554 2 391 244 566 3 310 193 457 8 28 5 75
Syria 1 522 355 726 2 174 108 260 3 124 74 189 9 5 1 18
Tunisia 1 521 375 706 2 208 134 305 3 131 82 198 8 8 1 28
UAE 1 508 358 688 2 205 126 301 3 135 83 205 8 27 7 65
Yemen 1 279 183 417 2 101 61 160 3 81 48 128 8 2 0 8
Sudan 1 324 237 421 2 123 81 173 3 108 72 155 9 3 0 10
Afghanistan 1 525 385 695 2 206 138 295 3 154 99 236 8 3 0 13
Pakistan 1 491 375 620 2 126 78 183 3 119 77 174 7 47 18 89
Djibouti 1 340 236 499 2 54 30 94 3 54 32 86 8 13 4 33
Somalia 1 180 120 267 2 60 34 100 3 33 19 54 7 9 2 22 Rate: DALYs per 100,000 persons of all ages; UI: Uncertainty Interval; EMR: The Eastern Mediterranean region; UAE: United Arab Emirates
SUPPLEMENTARY DATA
©2018 American Diabetes Association. Published online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc16-1075/-/DC1
6
Supplementa Table 5. Attributable diabetes burden to each risk factor of diabetes and ranking of risk factors in the Eastern
Mediterranean region (EMR) and countries of the region compared to the global level, 2013, continued.
ry
Location
Diet high in sugar sweetened beverages
Diet low in nuts and seeds
Smoking Diet high in red meat Alcohol use
Rank Rate 95% UI Rank Rate 95% UI Rank Rate 95% UI Rank Rate 95% UI Rank Rate 95% UI
Global 5 67 51 88 6 53 33 75 7 48 14 84 8 44 34 56 9 4 -5 12
EMR 5 57 36 85 6 53 32 79 7 47 12 85 4 58 45 73 9 4 2 6
Bahrain 4 172 89 277 7 78 38 134 6 85 23 160 5 97 50 160 9 3 -11 26
Egypt 6 64 32 108 4 99 63 143 7 63 16 117 5 67 46 92 8 9 5 14
Iran 8 7 2 16 6 19 8 33 5 25 7 48 4 41 27 60 9 1 -2 6
Iraq 4 63 33 105 7 46 22 76 6 53 15 97 5 57 31 96 9 2 -1 6
Jordan 4 113 61 190 6 79 43 123 5 91 27 164 7 72 46 106 9 2 -3 9
Kuwait 4 129 68 222 7 75 38 121 6 78 19 151 5 116 71 174 9 2 -2 8
Lebanon 4 142 89 213 7 23 9 44 6 97 30 176 5 111 69 169 9 1 -14 23
Libya 4 92 43 155 6 62 30 103 7 61 15 121 5 74 48 109 9 4 0 9
Morocco 4 91 48 150 5 81 45 122 7 56 14 108 6 66 45 93 8 11 5 17
Palestine 6 43 18 75 7 38 18 66 4 52 14 94 5 48 24 82 9 2 0 5
Oman 4 79 41 133 6 53 27 87 7 29 7 59 5 62 33 104 9 4 -2 12
Qatar 4 123 63 220 7 58 25 102 6 59 13 121 5 73 28 138 9 2 -8 16
Saudi Arabia 5 125 59 217 4 144 80 221 7 67 17 138 6 102 61 157 9 2 -5 9
Syria 4 50 24 85 7 16 6 30 6 37 11 73 5 47 29 72 8 6 2 12
Tunisia 5 63 30 111 7 39 20 65 4 71 20 134 6 41 25 62 9 5 -2 14
UAE 5 94 33 186 6 39 17 67 7 33 8 69 4 99 58 154 9 11 -3 31
Yemen 5 25 11 45 4 41 23 68 7 16 5 32 6 22 13 33 9 1 0 3
Sudan 4 31 16 53 6 27 14 45 7 5 1 11 5 31 16 52 8 5 -1 12
Afghanistan 6 39 19 68 5 49 25 82 7 34 9 66 4 56 29 94 9 2 -2 5
Pakistan 5 63 33 104 8 45 24 71 6 56 16 105 4 67 43 93 9 2 1 4
Djibouti 6 32 17 58 5 44 26 74 4 44 13 82 7 25 15 38 9 -4 -8 0
Somalia 5 21 9 37 4 28 15 48 6 16 4 33 8 7 3 13 9 -1 -3 1 Rate: DALYs per 100,000 persons of all ages; UI: Uncertainty Interval; EMR: The Eastern Mediterranean region; UAE: United Arab Emirates
SUPPLEMENTARY DATA
©2018 American Diabetes Association. Published online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc16-1075/-/DC1
7
Supplementa Table 6. Population attributable fraction of deaths and disability-adjusted life years (DALYs) of diabetes to different risk
factors for diabetes in the Eastern Mediterranean Region, 2013
ry
Risk factors
Population attributable fraction Attributable diabetes burden (rate per 100,000)
PAF
DALYs
95% UI (PAF
DALYs)
PAF
deaths
95% UI (PAF
deaths)
Rate of
diabetes
DALYs
95% UI DALY
rate
Rate of
Diabetes
deaths
95% UI
Death Rate
High fasting
plasma glucose 100% - - 100% - - 883.5 732.2 1051.5 19.5 17.4 21.5
High body mass
index 65.5% 60.2% 70.0% 55.6% 49.0% 62.0% 578.8 461.0 705.7 10.8 9.1 12.6
Low whole
grains 20.9% 16.4% 25.4% 16.6% 12.6% 20.5% 184.9 129.6 244.8 3.2 2.4 4.1
Physical
inactivity 16.5% 11.8% 21.5% 18.3% 13.1% 23.9% 145.5 97.6 202.0 3.6 2.6 4.8
High sweetened
beverages 6.6% 5.7% 7.5% 5.1% 4.3% 6.0% 58.3 44.9 73.3 1.0 0.8 1.2
Low nuts and
seeds 6.4% 4.4% 8.7% 3.7% 2.4% 5.4% 56.7 36.5 84.7 0.7 0.5 1.1
High red meat 6.0% 4.0% 8.3% 5.1% 3.4% 7.0% 53.5 32.1 78.6 1.0 0.6 1.4
Smoking 5.3% 1.4% 9.4% 5.3% 1.5% 9.6% 46.5 12.4 85.4 1.0 0.3 1.9
High processed
meat 2.3% 0.9% 4.5% 1.7% 0.6% 3.6% 20.1 7.4 42.2 0.3 0.1 0.7
Alcohol use 0.4% 0.2% 0.6% 0.5% 0.3% 0.7% 3.6 1.9 5.6 0.1 0.1 0.1
PAF: Population Attributable Fraction
SUPPLEMENTARY DATA
©2018 American Diabetes Association. Published online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc16-1075/-/DC1
8
Supplementa Table 7. Decomposition analysis of the change in total disability-adjusted life years (DALYs) from 1990 to 2013 into total
population growth, population aging, and changes in age-sex-specific DALY rates of diabetes for the Eastern Mediterranean Region
ry
Value 95% Uncertainty
interval
1990 total DALYs* (thousands) 222.1 187.5 262.8
Total DALYs expected with 2013 population, 1990 population age structure, 1990 DALY rates
(thousands) 361.9 305.5 428.2
Total DALYs expected with 2013 population, 2013 population age structure, 1990 DALY rates
(thousands) 432.2 364.9 511.4
2013 total DALYs (thousands) 551.4 457.0 656.2
Median percent change of DALYs during 1990 to 2013 due to population growth 62.9% 61.5% 64.8%
Median percent change of DALYs during 1990 to 2013 due to population aging 31.8% 30.5% 33.6%
Median percent change of DALYs during 1990 to 2013 due to change in DALY rates 53.9% 52.0% 56.0%
Median percent change of DALYs during 1990 to 2013 (Total) 148.2% 146.3% 150.7%
*All DALYs in this table reflect diabetes burden
SUPPLEMENTARY DATA
©2018 American Diabetes Association. Published online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc16-1075/-/DC1